GlaxoSmithKline (GSK) Malaria Partnership

The GlaxoSmithKline (GSK) Malaria Partnership is an initiative by the pharmaceutical company GSK to develop and deliver effective malaria medicines and vaccines, especially for vulnerable populations in affected regions. It involves collaboration with governments, organizations, and researchers to improve access to affordable, innovative treatments. The partnership aims to reduce the burden of malaria—a serious disease caused by parasites transmitted through mosquito bites—by advancing scientific research, increasing awareness, and supporting public health efforts to save lives and eliminate the disease in endemic areas.